Pulse Biosciences Inc.
PLSE | NASDAQ
$53.47
+$1.23 (+2.35%)
Nov 2, 2026, 11:00 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -12.71 | -18.92 | -13.91 | -1.61 | -6.50 | -11.15 |
PEG Ratio | -0.73 | -4.16 | 0.28 | 0.07 | -0.99 | 3.09 |
PS Ratio | 2.64K | n/a | n/a | 134.29 | 292.06 | n/a |
PB Ratio | 11.47 | 8.85 | 13.25 | -41.81 | 11.60 | 24.23 |
P/FCF Ratio | -17 | -27.88 | -17.73 | -1.98 | -7.59 | -15.49 |
P/OCF Ratio | -17.10 | -27.98 | -17.80 | -2 | -7.66 | -15.68 |
OCF/S Ratio | -15.46K | n/a | n/a | -6.72K | -3.82K | n/a |
Debt / Equity Ratio | 0.09 | 0.08 | 0.21 | -33.79 | 0.32 | 0.50 |
Quick Ratio | 10.51 | 11.88 | 6.76 | 10.39 | 3.62 | 2.95 |
Current Ratio | 10.53 | 11.88 | 6.76 | 10.39 | 4.30 | 2.95 |
Asset Turnover | 0 | n/a | n/a | 0.01 | 0.03 | n/a |
Interest Coverage | n/a | n/a | -39.61 | -129.59 | -97.54 | n/a |
Return on Equity | -90.24% | -46.65% | -95.15% | 2.6K% | -178.37% | -217.25% |
Return on Assets | -75.72% | -40.45% | -71.36% | -75.12% | -117.35% | -120.45% |
Return on Invested Capital | -85.72% | -45.46% | -81.44% | -78.77% | -134.24% | -145.88% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -360% | n/a | n/a | -1.61K% | -38.79% | n/a |
Net Profit Margin | -20.79K% | n/a | n/a | -8.36K% | -4.49K% | n/a |
Pretax Profit Margin | -20.79K% | n/a | n/a | -8.36K% | -4.49K% | n/a |
Operating Profit Margin | -21.98K% | n/a | n/a | -8.29K% | -4.44K% | n/a |
FCF Margin | -15.55K% | n/a | n/a | -6.77K% | -3.85K% | n/a |
EBITDA Margin | -20.49K% | n/a | n/a | -8.16K% | -4.41K% | n/a |
Add to Watchlist
Select watchlists to add or remove PLSE